The National Institutes of Pharmaceutical Education and Research Act, 1998

Summary of the National Institutes of Pharmaceutical Education and Research Act, 1998

Key Provisions
1. Declaration of National Importance: - Declares certain institutions of pharmaceutical education and research as institutions of national importance (listed in the Schedule, e.g., Mohali, Ahmedabad, Hajipur, Hyderabad, Kolkata, Guwahati, Raebareli).
2. Establishment and Incorporation: - Institutes are bodies corporate with perpetual succession and a common seal.
• Power to acquire, hold, dispose of property, and to contract.
3. Governance: - Board of Governors for each Institute, comprising:
• Chairperson (nominated by the Visitor)
• Director (ex officio)
• Various ex officio members from Government and industry
• Nominated experts and professors
• Council (established under Section 30A) for coordinating activities across Institutes, with specified functions and powers.
4. Functions of Institutes (Section 7):
• Nurture quality in pharmaceutical education and research
• Develop graduate, postgraduate, doctoral, and post-doctoral programs
• Conduct examinations, grant degrees
• Cooperate with similar institutions
• Various other educational, research, and development activities
5. Powers and Financial Provisions: - Powers of the Board (outlined in context, though detailed section not fully provided)
• Provisions for grants, fund management, endowment funds, accounts, and audit.
6. Employment and Service Conditions: - Continuity of service for employees from the preceding Society with the same terms and conditions.
7. Legislative and Regulatory Framework: - Provisions for Statutes, Ordinances, and their publication and laying before Parliament.
• Power to make rules for the Council’s functioning.
8. Repeal and Saving Clause: - Repeals the National Institute of Pharmaceutical Education and Research Ordinance, 1998, with a saving clause for actions taken under the repealed ordinance.

Legislative History:

The National Institute of Pharmaceutical Education and Research Act, 1998

Short Title The National Institute of Pharmaceutical Education and Research Act, 1998

Act Number / Year 13 of 1998

Act ID (India Code) 199813

Presidential Assent / Enactment Date June 26, 1998

Enforcement Date July 8, 1998

Nodal Ministry Ministry of Chemicals and Fertilizers

Precedent & Statutory Rationale

• Absence of Specialized Apex Pharmaceutical Research Infrastructure:

o Prior to 1998, despite India's expanding role as a major global hub for generic drug manufacturing, there was a lack of dedicated, autonomous national institutes possessing statutory authority to award high-level degrees and lead advanced research and development explicitly in pharmaceutical sciences.

o Existing medical and general technical universities treated pharmacy as a secondary discipline, failing to provide the specialized infrastructure required to meet evolving global pharmaceutical standards and clinical research demands.

• Legislative Intervention and Regularization:

o Enacted to formally establish the National Institute of Pharmaceutical Education and Research (NIPER) at SAS Nagar (Mohali) and grant it the status of an "institution of national importance."

o The core objective was to foster excellence in higher education, research, and training in pharmaceutical sciences, promote collaboration with the pharmaceutical industry, and establish national standards for advanced education and specialized degrees in the sector.

Parliamentary Trajectory & Enactment

• Formulation: Conceived by the Central Government to fulfill strategic science and technology objectives aimed at boosting indigenous pharmaceutical research, development, and quality control capabilities.

• Parliamentary Passage: Passed by both houses of Parliament, receiving formal presidential assent on June 26, 1998.

• Enforcement: Enforced on July 8, 1998.

• Source: India Code and Ministry of Chemicals and Fertilizers Official Records.